CAS: 1427501-69-6 - 5-Chloro-2-[[(1,1-dimethylethoxy)carbonyl]amino]-2,3-dihydro-1H-indene-2-carboxylic acid
Formula:C15H18ClNO4
InChI:InChI=1S/C15H18ClNO4/c1-14(2,3)21-13(20)17-15(12(18)19)7-9-4-5-11(16)6-10(9)8-15/h4-6H,7-8H2,1-3H3,(H,17,20)(H,18,19)
InChI key:InChIKey=ZIVWELCPNMCVLQ-UHFFFAOYSA-N
SMILES:O=C(OC(C)(C)C)NC1(C(=O)O)CC2=CC=C(Cl)C=C2C1
- Synonyms:
- 5-Chloro-2-[[(1,1-dimethylethoxy)carbonyl]amino]-2,3-dihydro-1H-indene-2-carboxylic acid
- 1H-Indene-2-carboxylic acid, 5-chloro-2-[[(1,1-dimethylethoxy)carbonyl]amino]-2,3-dihydro-
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
2-((tert-Butoxycarbonyl)amino)-5-chloro-2,3-dihydro-1H-indene-2-carboxylic acid REF: IN-DA00HWM5CAS: 1427501-69-6 | 95% | To inquire | Thu 12 Dec 24 | |
2-(BOC-AMINO)-5-CHLORO-2,3-DIHYDRO-1H-INDENE-2-CARBOXYLIC ACID REF: 10-F330796CAS: 1427501-69-6 | 95.0% | To inquire | Fri 27 Dec 24 | |
2-(boc-amino)-5-chloro-2,3-dihydro-1h-indene-2-carboxylic acid REF: 3D-CHC50169CAS: 1427501-69-6 | Min. 95% | - - - | Discontinued product |
2-((tert-Butoxycarbonyl)amino)-5-chloro-2,3-dihydro-1H-indene-2-carboxylic acid
CAS:1427501-69-6
Formula:
C15H18ClNO4
Purity:
95%
Molecular weight:
311.7607
Ref: IN-DA00HWM5
1g | To inquire | ||
100mg | 287.00 € | ||
250mg | 498.00 € |
Estimated delivery in United States, on Thursday 12 Dec 2024
2-(BOC-AMINO)-5-CHLORO-2,3-DIHYDRO-1H-INDENE-2-CARBOXYLIC ACID
CAS:1427501-69-6
Purity:
95.0%
Molecular weight:
311.760009765625
Ref: 10-F330796
1g | To inquire | ||
250mg | To inquire |
Estimated delivery in United States, on Friday 27 Dec 2024
2-(boc-amino)-5-chloro-2,3-dihydro-1h-indene-2-carboxylic acid
CAS:1427501-69-6
Versatile small molecule scaffold
Formula:
C15H18ClNO4
Purity:
Min. 95%
Molecular weight:
311.76 g/mol
Ref: 3D-CHC50169
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
10mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |